SELLAS Life Sciences (SLS) announced data from preclinical studies identifying ASXL1 mutation as key predictor of SLS009, a highly selective ...

High Efficacy of SLS009 Observed in 67% of ASXL1 Mutated Solid Cancers vs 0% in Non-ASXL1 Mutated Cancers – - ASXL1 Mutations Predictably Identified in Colorectal Cancer (CRC MSI-H) and Non-Small Cell ...

According to the national cancer registration business annual report (2021 cancer registration statistics), the five-year ...

TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but ...

For those diagnosed with a tumour, your doctor would first determine whether it is benign or malignant. Benign tumours are ...

Plus Therapeutics subsidiary CNSide Diagnostics has reported data from the multi-centre FORESEE trial, which highlights the ...

NP-101 plus nivolumab and ipilimumab demonstrated activity in patients with metastatic EP-NECs that were refractory to chemotherapy.

Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

If people have had sunburn, especially as a child, skin cancer can develop and if not treated early can prove fatal ...

The following is a summary of “Phase 2 Trial of Topical Application of the Hedgehog Inhibitor Patidegib in Patients With ...

A research team led by Kim Chan, Jeon Hong-jae, a professor of hematologic oncology at Bundang Cha Hospital (Director Yoon ...

The global liquid biopsy market size was valued at USD 10.99 billion in 2024 and is projected to reach from USD 12.23 billion ...